Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Intraocular Pressure: later-stage trial registry

4 of 10 indexed Intraocular Pressure trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 4 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Intraocular Pressure: 10 US clinical trials tracked, 4 recruiting.

Intraocular Pressure is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 2 of these trials.

Enrollment posture brief

Registry condition intraocular-pressure

OPEN 4 | RECR 40% | LATE 4 | EARLY 0 | RANK #1724 | SPON 2

Nearest open-share peer: Acute Myeloid Leukemia (AML) (40% recruiting · 30 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Intraocular Pressure (this)40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Intraocular Pressure

Intraocular Pressure lists 4 open slots (40% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intraocular Pressure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intraocular Pressure is recruiting below its size-band peers.

    4 of 10 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Intraocular Pressure research.

    University of Utah accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Intraocular Pressure enrolment sits around 107 participants.

    Median target enrolment is 107 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.

  4. Intraocular Pressure research is mostly interventional.

    8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 44

Open and recent trials

10 total, page 1 of 1

RECRUITING NA 150 participants

IOP Elevation Study

NYU Langone Health

NCT03400137

RECRUITING 125 participants

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

Smartlens

NCT06689696

RECRUITING Phase 4 40 participants

Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients

University of Florida

NCT04281017

RECRUITING NA 20 participants

Effect of Raised End-Tidal pCo2 on Choroidal Volume

University of Pittsburgh

NCT06275308

ACTIVE NOT RECRUITING 116 participants

Anterior Segment Optical Coherence Tomography Microstent Positioning

University of Utah

NCT06666751

COMPLETED Phase 4 131 participants

Loteprednol vs. Prednisolone and Fluorometholone

University of Utah

NCT03123614

COMPLETED NA 107 participants

Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings

The University of Texas Health Science Center, Houston

NCT02837536

COMPLETED NA 45 participants

Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure

Northwestern University

NCT02448043

COMPLETED Phase 4 36 participants

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

Nicole Fram M.D.

NCT04521140

COMPLETED Phase 4 25 participants

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Bp Consulting

NCT00828477

Phase Distribution

PhaseTrial count
Phase 4 4

Named interventions

Most-linked intervention names on Intraocular Pressure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Prednisolone Acetate 1% Oph Susp Drug
2 trials
Dextenza 0.4Mg Ophthalmic Insert Drug
1 trials
Vertical iCare Other
1 trials
Horizontal iCare Other
1 trials
Nevanac Drug
1 trials
Xibrom Drug
1 trials
Placebo: saline Other
1 trials
Bimatoprost 0.01% Drug
1 trials

US sites by state

Facility locations filed on Intraocular Pressure trials. A trial with sites in several states counts in each.

Utah 2 trials
California 2 trials
Texas 1 trials
Pennsylvania 1 trials
New York 1 trials
Michigan 1 trials
Illinois 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intraocular Pressure page

10 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Intraocular Pressure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Utah sponsors the most Intraocular Pressure trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intraocular Pressure condition card totals 10 registered trials; most-linked intervention Prednisolone Acetate 1% Oph Susp; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.